New nomenclature for fatty liver disease; product of many and necessary agreements
DOI:
https://doi.org/10.59093/27112330.97Abstract
The selection of a new name and definition for the condition formerly known as non-alcoholic fatty liver disease (NAFLD) has been a difficult and agreed-upon process, given the wide variation in concepts among different stakeholders worldwide, it was necessary for any new proposal to be better than the current one and sufficiently superior to the existing nomenclature to improve knowledge and understanding of the disease and to facilitate further research.
Downloads
References
Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. https://doi.org/10.1016/j.jhep.2023.06.003.
Thornton J. Associations rename fatty liver disease to reduce stigma. BMJ 2023;382:1587. https://doi.org/10.1136/bmj.p1587.
Asociación Latinoamericana para el Estudio del Hígado (ALEH), American Asociation for the Study of Liver Diseases (AASLD), European Association for the Study of the Liver (EASL). Multinational liver societies announce new “Fatty” liver disease nomenclature that is affirmative and non-stigmatising. Geneva, Switzerland: Multinational Liver Societies PR Team. Acceso 8 de agosto de 2023. Disponible en https://easl.eu/news/new_fatty_liver_disease_nomenclature-2/.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Hepatología’s authorship policy is based on the criteria established by the International Committee of Medical Journal Editors (ICMJE) to credit a person for their work while assigning them responsibility for its publication.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
